Your browser doesn't support javascript.
loading
Omicron-Specific Cytotoxic T-Cell Responses After a Third Dose of mRNA COVID-19 Vaccine Among Patients With Multiple Sclerosis Treated With Ocrelizumab.
Madelon, Natacha; Heikkilä, Nelli; Sabater Royo, Irène; Fontannaz, Paola; Breville, Gautier; Lauper, Kim; Goldstein, Rachel; Grifoni, Alba; Sette, Alessandro; Siegrist, Claire-Anne; Finckh, Axel; Lalive, Patrice H; Didierlaurent, Arnaud M; Eberhardt, Christiane S.
Afiliação
  • Madelon N; Faculty of Medicine, Center for Vaccinology, Department of Pathology and Immunology, University of Geneva, Geneva, Switzerland.
  • Heikkilä N; Faculty of Medicine, Center for Vaccinology, Department of Pathology and Immunology, University of Geneva, Geneva, Switzerland.
  • Sabater Royo I; Faculty of Medicine, Center for Vaccinology, Department of Pathology and Immunology, University of Geneva, Geneva, Switzerland.
  • Fontannaz P; Faculty of Medicine, Center for Vaccinology, Department of Pathology and Immunology, University of Geneva, Geneva, Switzerland.
  • Breville G; Division of Neurology, Department of Neurosciences, University Hospital of Geneva, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
  • Lauper K; Division of Rheumatology, Department of Medicine, University Hospital of Geneva, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
  • Goldstein R; Faculty of Medicine, Center for Vaccinology, Department of Pathology and Immunology, University of Geneva, Geneva, Switzerland.
  • Grifoni A; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, University of California, San Diego, La Jolla.
  • Sette A; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, University of California, San Diego, La Jolla.
  • Siegrist CA; Division of Infectious Diseases and Global Public Health, Department of Medicine, University of California, San Diego, La Jolla.
  • Finckh A; Faculty of Medicine, Center for Vaccinology, Department of Pathology and Immunology, University of Geneva, Geneva, Switzerland.
  • Lalive PH; Division of General Pediatrics, Department of Woman, Child and Adolescent Medicine, Faculty of Medicine, University of Geneva, Center for Vaccinology, Geneva University Hospitals, Geneva, Switzerland.
  • Didierlaurent AM; Division of Rheumatology, Department of Medicine, University Hospital of Geneva, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
  • Eberhardt CS; Division of Neurology, Department of Neurosciences, University Hospital of Geneva, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
JAMA Neurol ; 79(4): 399-404, 2022 04 01.
Article em En | MEDLINE | ID: mdl-35212717
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 4_TD Problema de saúde: 1_doencas_nao_transmissiveis / 2_muertes_prematuras_enfermedades_notrasmisibles / 4_pneumonia Assunto principal: COVID-19 / Esclerose Múltipla Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Humans / Male / Middle aged Idioma: En Revista: JAMA Neurol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Suíça
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 4_TD Problema de saúde: 1_doencas_nao_transmissiveis / 2_muertes_prematuras_enfermedades_notrasmisibles / 4_pneumonia Assunto principal: COVID-19 / Esclerose Múltipla Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Humans / Male / Middle aged Idioma: En Revista: JAMA Neurol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Suíça